<!doctype html>
<html lang="en" data-theme="">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width">
<meta name="generator" content="Docusaurus v2.0.0-alpha.49">
<link rel="stylesheet" href="https://use.typekit.net/rrd2zlt.css">

<title data-react-helmet="true">REMDESIVIR STUDY</title>

<meta data-react-helmet="true" http-equiv="x-ua-compatible" content="ie=edge"><meta data-react-helmet="true" property="og:title" content="C19HCC Cohorts · Cohorts and Metrics"><meta data-react-helmet="true" name="twitter:card" content="summary"><meta data-react-helmet="true" name="description" content="# Remdesivir"><meta data-react-helmet="true" property="og:description" content="# Remdesivir"><meta data-react-helmet="true" property="og:url" content="https://mcovid.org/docs/studies-remd">

<link data-react-helmet="true" rel="shortcut icon" href="/favicon.ico">


<link rel="stylesheet" href="/styles.4dcf3e50.css">


<link rel="preload" href="/styles.c2209197.js" as="script">

<link rel="preload" href="/runtime~main.f6672760.js" as="script">

<link rel="preload" href="/main.d2f9eb79.js" as="script">

<link rel="preload" href="/1.ef153c5f.js" as="script">

<link rel="preload" href="/2.bd3a3c4c.js" as="script">

<link rel="preload" href="/1be78505.d231f308.js" as="script">

<link rel="preload" href="/32.4124dd3b.js" as="script">

<link rel="preload" href="/9c9e4252.3d1fe3a8.js" as="script">

<link rel="preload" href="/17896441.1478afa4.js" as="script">

<link rel="preload" href="/e8314ad7.197e6704.js" as="script">

<link rel="preload" href="/5f3b9425.06a7c7df.js" as="script">

</head>
<body>

<div id="__docusaurus">
<nav class="navbar navbar--light navbar--fixed-top"><div class="navbar__inner"><div class="navbar__items"><div aria-label="Navigation bar toggle" class="navbar__toggle" role="button" tabindex="0"><svg xmlns="http://www.w3.org/2000/svg" width="30" height="30" viewBox="0 0 30 30" role="img" focusable="false"><title>Menu</title><path stroke="currentColor" stroke-linecap="round" stroke-miterlimit="10" stroke-width="2" d="M4 7h22M4 15h22M4 23h22"></path></svg></div><a aria-current="page" class="navbar__brand active" href="/"><img class="navbar__logo" src="/img/Coalition-logo.svg" alt="MITRE C19HCC"></a></div><div class="navbar__items navbar__items--right"><a class="navbar__item navbar__link" href="/docs/studies/">STUDIES</a><a class="navbar__item navbar__link" href="/docs/cohorts/">COHORTS</a><a class="navbar__item navbar__link" href="/docs/vocabulary/">VOCABULARY</a><a class="navbar__item navbar__link" href="/dictionary/">DICTIONARY</a><div class="navbar__search"><span aria-label="expand searchbar" role="button" class="search-icon" tabindex="0"></span></div></div></div><div role="presentation" class="navbar-sidebar__backdrop"></div><div class="navbar-sidebar"><div class="navbar-sidebar__brand"><a aria-current="page" class="navbar__brand active" href="/"><img class="navbar__logo" src="/img/Coalition-logo.svg" alt="MITRE C19HCC"></a></div><div class="navbar-sidebar__items"><div class="menu"><ul class="menu__list"><li class="menu__list-item"><a class="menu__link" href="/docs/studies/">STUDIES</a></li><li class="menu__list-item"><a class="menu__link" href="/docs/cohorts/">COHORTS</a></li><li class="menu__list-item"><a class="menu__link" href="/docs/vocabulary/">VOCABULARY</a></li><li class="menu__list-item"><a class="menu__link" href="/dictionary/">DICTIONARY</a></li></ul></div></div></div></nav><div class="main-wrapper"><div class="docPage_1kjD"><main class="docMainContainer_FFX1"><div class="padding-vert--lg"><div class="container"><div class="row"><div class="col"><div class="docItemContainer_2cwg"><article><div class="markdown"><h1><a aria-hidden="true" tabindex="-1" class="anchor" id="remdesivir"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#remdesivir" title="Direct link to heading">#</a>Remdesivir</h1><p><strong>RESEARCH QUESTION: For patients with new COVID-19 infection, how does the addition of Remdesivir affect the outcomes (1) severe disease (indicated by mechanical ventilation) and (2) inpatient death?</strong></p><blockquote><p>Notice:
This content is rough draft or placeholder quality, and is expected to change quickly as we work with C19HCC partners to align and refine definitions.</p></blockquote><h3><a aria-hidden="true" tabindex="-1" class="anchor" id="background"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#background" title="Direct link to heading">#</a>Background</h3><p>Remdesivir are currently under study as possible treatments for COVID-19. Before randomized clinical trials read out, a retrospective observational study can provide insight into the efficacy of this drug.</p><h3><a aria-hidden="true" tabindex="-1" class="anchor" id="study-design"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#study-design" title="Direct link to heading">#</a>Study Design</h3><p>The study examines the effect of initiation of Remdesivir in hospitalized COVID-19 patients on disease severity. The study involves two study groups (those receiving or not receiving Remdesivir), as depicted below:</p><p><strong>Study Period</strong>: January 1, 2020 - Present (Index date: <code>COVID-19-positive-date</code>)</p><p><img src="remd_cohorts.png" alt="Remdesivir cohort pathways"></p><p>Three outcomes are considered:</p><ol><li>Discharge without being placed on mechanical ventilation during stay</li><li>Discharge after invasive mechanical ventilation (IMV) during stay</li><li>Inpatient death</li></ol><p>These outcomes correspond to increasing levels disease severity. The study uses mechanical ventilation as a proxy for severe but non-fatal disease. The outcome is retrospective over the entire patient visit and capture the worst severity of illness during the visit. For example:</p><ul><li>Patient is put on a ventilator (level 2) and then succumbs to the disease (level 3); the outcome is level 3 (death).</li><li>Patient is temporarily put on a ventilator (level 2), then taken off the ventilator (level 1) and discharged; the outcome level 2.</li></ul><h3><a aria-hidden="true" tabindex="-1" class="anchor" id="study-populations"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#study-populations" title="Direct link to heading">#</a>Study Populations</h3><ul><li><strong>Entry Cohort</strong>:<ul><li>Age at <code>COVID-19-positive-date</code> ≥ 18 years AND</li><li><code>COVID-19-positive-date</code> after Jan 1, 2020 AND</li><li><code>COVID-19-related hospitalization</code></li></ul></li><li><strong>Target Cohort</strong>:<ul><li>Entry Cohort AND</li><li><code>Inpatient-Remdesivir-use</code> AND NOT <code>Prior-Remdesivir-use</code> [1]</li></ul></li><li><strong>Control Cohort</strong>:<ul><li>Entry Cohort AND</li><li>NOT <code>Inpatient-Remdesivir-use</code> AND NOT <code>Prior-Remdesivir-use</code> [1]</li></ul></li></ul><h3><a aria-hidden="true" tabindex="-1" class="anchor" id="definitions"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#definitions" title="Direct link to heading">#</a>Definitions</h3><ul><li><code>COVID-19-positive</code> [2]:<ul><li>Any clinical diagnosis [3] code in set <code>C19HCC Confirmed COVID-19 infection</code> OR</li><li><code>Positive</code> or <code>detected</code> result from any test in set <code>C19HCC SARS-CoV-2 Qualitative Laboratory Test</code> [4] OR</li><li><code>Positive</code> or <code>detected</code> result from any test in set <code>C19HCC SARS-related Qualitative Laboratory Test</code> [4]</li></ul></li><li><code>COVID-19-positive-date</code>: earliest date of <code>COVID-19-positive</code> [5]</li><li><code>Hospitalization</code>:<ul><li>encounter with class or type like <code>inpatient encounter</code> AND</li><li>encounter status like <code>completed</code></li></ul></li><li><code>COVID-19-related-hospitalization</code>: [6]<ul><li><code>COVID-19-positive-date</code> during <code>hospitalization</code> OR</li><li>(<code>hospitalization</code> up to 14 days after <code>COVID-19-positive-date</code>) AND (any clinical or billing diagnosis of <code>Respiratory Condition</code> associated with the hospitalization [7])</li></ul></li><li><code>Prior-Remdesivir-use</code>:<ul><li><code>Hydroxychloroquine</code> on admission medication list or outpatient medication list</li></ul></li><li><code>Inpatient-Remdesivir-use</code>:<ul><li><code>Hydroxychloroquine</code> medication administration during <code>COVID-19-related-hospitalization</code><ul><li>Includes any dose, form, duration of Remdesivir</li><li>Includes any level of disease severity while on Remdesivir</li><li>Includes patients on other medications</li></ul></li></ul></li></ul><h4><a aria-hidden="true" tabindex="-1" class="anchor" id="study-cohort-examples"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#study-cohort-examples" title="Direct link to heading">#</a>Study Cohort Examples</h4><p>Person A (included in study):</p><ul><li>Presents with fever and difficulty breathing</li><li>Admitted with diagnosis of suspected COVID-19</li><li>Tests positive during hospital stay (even if results received after discharge)</li><li>No history of Remdesivir usage</li></ul><p>Person B (excluded from study):</p><ul><li>Presents with fever and difficulty breathing</li><li>Admitted with diagnosis of suspected COVID-19</li><li>Tests positive during hospital stay</li><li>Taking Remdesivir for lupus</li></ul><p>Person C (included in study):</p><ul><li>Has fever and cough</li><li>Swabbed for COVID-19, sent home</li><li>Test results positive</li><li>Arrives at hospital 10 days later with dyspnea</li><li>Admitted</li><li>No history of Remdesivir usage</li></ul><p>Person D (excluded from study):</p><ul><li>Presents with fever, difficulty breathing</li><li>Admitted with admission diagnosis of suspected COVID-19</li><li>Tests negative for COVID-19</li><li>No history of Remdesivir usage</li></ul><p>Person E (included from study):</p><ul><li>Admitted to hospital for congestive heart failure</li><li>During stay, experiences fever and cough</li><li>During stay, tests positive for COVID-19</li><li>No history of Remdesivir usage</li></ul><p>Person F (excluded from study):</p><ul><li>Asymptomatic</li><li>Tests positive for COVID-19 during outpatient population screening</li><li>Admitted to hospital 5 days later for trauma injury</li><li>No history of Remdesivir usage</li></ul><p>Person F (included in study):</p><ul><li>Has fever and cough</li><li>Swabbed for COVID-19, sent home</li><li>Test results positive</li><li>Arrives at hospital 22 days later with dyspnea</li><li>Admitted with suspected COVID-19</li><li>Receives clinical diagnosis of COVID-19 as inpatient</li></ul><h3><a aria-hidden="true" tabindex="-1" class="anchor" id="outcomes"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#outcomes" title="Direct link to heading">#</a>Outcomes</h3><ul><li><p><strong>Invasive Mechanical Ventilation (IMV)</strong>:</p><ul><li><code>Invasive mechanical ventilation</code> procedure during <code>COVID-19-related-hospitalization</code> OR</li><li>Evidence mechanical ventilation in ICU flowsheet documentation (e.g. ventilator mode change)[8]</li></ul></li><li><p><strong>COVID-19 Inpatient Death</strong>:</p><ul><li><code>COVID-19 related hospitalization</code> discharge disposition like <code>expired</code> OR date of death is during <code>COVID-19 related hospitalization</code></li></ul></li></ul><h3><a aria-hidden="true" tabindex="-1" class="anchor" id="value-sets"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#value-sets" title="Direct link to heading">#</a>Value Sets</h3><ul><li><a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.117/expansion/Latest">C19HCC Confirmed COVID-19 Infection</a> (SNOMED CT, ICD-10-CM)</li><li><a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.109/expansion/Latest">C19HCC SARS-CoV-2 Qualitative Laboratory Test</a> (LOINC)</li><li><a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.113/expansion/Latest">C19HCC SARS-related Qualitative Laboratory Test</a> (LOINC)</li><li>Respiratory Condition (ICD-10-CM J00-J99)</li><li><a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1564.2220/expansion/Latest">Hydroxychloroquine</a> (RxNorm)</li><li>Invasive mechanical ventilation: Any intubation procedure or mechanical ventilation-associated procedure. Excludes supplemental oxygen (high or low flow), CPAP, and BiPAP, ECMO (SNOMED CT, CPT, ICD-10-PCS)</li></ul><h4><a aria-hidden="true" tabindex="-1" class="anchor" id="notes"></a><a aria-hidden="true" tabindex="-1" class="hash-link" href="#notes" title="Direct link to heading">#</a>Notes:</h4><p>[1] Patients with prior use of Remdesivir (e.g., as treatment for autoimmune disease) are excluded from study<br>
[2] Study includes confirmed cases only<br>
[3] A clinical diagnosis can be any diagnosis associated with an encounter, such as chief complaint, admitting diagnosis, working diagnosis, final diagnosis, or discharge diagnosis. It can also be a problem list entry.<br>
[4] There may be local value sets/groupers for laboratory tests to detect SARS-CoV-2. Only PCR and NAAT tests with qualitative results should be considered for this purpose. See <a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.109/expansion/Latest">C19HCC SARS-CoV-2 Qualitative Laboratory Test</a> and <a href="">C19HCC SARS-related Qualitative Laboratory Test</a> for details on inclusions and exclusions.<br>
[5] The relevant date for laboratory test is the specimen collection data, not when results are reported. Laboratory order date can be used when specimen collection date is not available.<br>
[6] This definition includes patients diagnosed with COVID-19 during a hospital visit even if the reason for hospitalization is not COVID-related; e.g., patients with undetected COVID-19 admitted for other reasons, and nosocomial COVID-19 infections ​<br>
[7] Serves a confirmation that hospital admission is related to COVID-19 infection (as opposed to broken arm, etc.)<br>
[8] ICU flowsheet data may not be accessible to all data partners</p></div></article><div class="margin-vert--lg"><nav class="pagination-nav"><div class="pagination-nav__item"></div><div class="pagination-nav__item pagination-nav__item--next"></div></nav></div></div></div><div class="col col--3"><div class="tableOfContents_TbNY"><ul class="contents contents__left-border"><li><a href="#background" class="contents__link">Background</a></li><li><a href="#study-design" class="contents__link">Study Design</a></li><li><a href="#study-populations" class="contents__link">Study Populations</a></li><li><a href="#definitions" class="contents__link">Definitions</a></li><li><a href="#outcomes" class="contents__link">Outcomes</a></li><li><a href="#value-sets" class="contents__link">Value Sets</a></li></ul></div></div></div></div></div></main></div></div><footer class="nav-footer_2_Kf" id="footer"><div class="footerWrapper_2yPB"><div class="footerLogo_2_Nc"></div><div><section class="footerLinks_hdHB"></section><section class="legal-text_3jBI">© 2020, The MITRE Corporation. Approved for Public Release, Distribution Unlimited 19-03332.</section><section class="legal-text_3jBI"><a href="https://www.icgc-argo.org" target="_blank">Based on the ICGC ARGO Data Platform</a> </section></div><div class="footerLogo_2_Nc"></div></div></footer>
</div>

<script src="/styles.c2209197.js"></script>

<script src="/runtime~main.f6672760.js"></script>

<script src="/main.d2f9eb79.js"></script>

<script src="/1.ef153c5f.js"></script>

<script src="/2.bd3a3c4c.js"></script>

<script src="/1be78505.d231f308.js"></script>

<script src="/32.4124dd3b.js"></script>

<script src="/9c9e4252.3d1fe3a8.js"></script>

<script src="/17896441.1478afa4.js"></script>

<script src="/e8314ad7.197e6704.js"></script>

<script src="/5f3b9425.06a7c7df.js"></script>


</body>
</html>